ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,905,000 | +1153.7% | 63,537 | +704.3% | 0.05% | +980.0% |
| Q3 2021 | $471,000 | -41.2% | 7,900 | -24.2% | 0.01% | -54.5% |
| Q4 2020 | $801,000 | -37.7% | 10,423 | -39.4% | 0.01% | -54.2% |
| Q3 2020 | $1,286,000 | -57.0% | 17,197 | -73.5% | 0.02% | -82.0% |
| Q3 2018 | $2,991,000 | +5.5% | 65,000 | 0.0% | 0.13% | -13.6% |
| Q2 2018 | $2,834,000 | +377.9% | 65,000 | +333.3% | 0.15% | +250.0% |
| Q1 2018 | $593,000 | – | 15,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |